静脉注射对乙酰氨基酚对内镜鼻窦手术术后疼痛的镇痛效果:随机临床试验
这项前瞻性随机临床试验纳入62例因慢性鼻窦炎接受内镜鼻窦手术的患者,比较围手术期静脉注射对乙酰氨基酚(IVAPAP)1g与安慰剂(生理盐水100mL)对术后早期疼痛的影响。主要结局为术后24小时内盲法评估的视觉模拟量表(VAS)疼痛评分。结果显示,术后1小时内IVAPAP组疼痛评分较对照组降低,最大差异为7.7mm(VAS),但置信区间宽且包含无效值;12小时和24小时平均疼痛评分安慰剂组更低,差异分别为5.8mm和8.2mm,同样置信区间宽且包含无效值。结论为结果不确定,数据提示IVAPAP可能减少即刻术后疼痛和阿片类药物需求,但估计不精确无法定论,且未增加不良事件。
要点
- 术后1小时内IVAPAP组VAS疼痛评分较对照组降低,最大差异7.7mm,但置信区间宽包含无效值。
- 12小时和24小时平均疼痛评分安慰剂组更低,差异分别为5.8mm和8.2mm,置信区间宽包含无效值。
- 次要结局倾向IVAPAP但置信区间宽,使用IVAPAP似乎不增加不良事件。
核心结论
- 研究结果不确定;数据提示围手术期静脉注射对乙酰氨基酚可能减少即刻术后疼痛和阿片类药物需求,差异可能具有临床意义,但估计不精确无法定论。
- 使用IVAPAP似乎不增加不良事件。
研究设计与样本
- 前瞻性随机临床试验,纳入62例因慢性鼻窦炎接受内镜鼻窦手术的患者,来自单一三级转诊医院。
- 60例随机分组:31例接受IVAPAP 1g,29例接受安慰剂(生理盐水100mL),于手术开始前和首次剂量后4小时输注。
- 主要结局为术后24小时内盲法观察者测量的VAS疼痛评分;次要终点包括术后24小时内阿片类药物(静脉和口服)使用及不良事件。
主要发现
- 术后1小时内,IVAPAP组平均疼痛评分较对照组降低,最大差异为7.7mm(VAS),真实差异可能高达22mm,数据与临床有意义差异相容。
- 12小时和24小时平均疼痛评分安慰剂组更低,数据与临床有意义差异相容,分别为5.8(-5.2至16.8)和8.2(-1.9至18.4),倾向安慰剂组。
- 所有时间点置信区间均包含无效值且宽,无法定论;次要结局倾向IVAPAP但置信区间宽且包含无效值,无法定论。
关键数值与推荐
- IVAPAP剂量为1g,安慰剂为生理盐水100mL,于手术开始前和首次剂量后4小时输注。
- 主要结局为VAS疼痛评分,术后1小时内最大差异7.7mm,12小时差异5.8(-5.2至16.8),24小时差异8.2(-1.9至18.4)。
临床怎么用
- 围手术期静脉注射对乙酰氨基酚可能减少即刻术后疼痛和阿片类药物需求,但证据不确定,需结合临床判断。
- 使用IVAPAP似乎不增加不良事件。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intravenous acetaminophen is a commonly prescribed analgesic for the prevention and treatment of postsurgical pain. Its efficacy in the context of endoscopic sinus surgery (ESS) has yielded mixed results. OBJECTIVE: To compare the efficacy of perioperative intravenous acetaminophen (IVAPAP) with that of placebo in improving early postoperative pain after endoscopic sinus surgery (ESS). DESIGN, SETTING, AND PARTICIPANTS: A prospective, randomized clinical trial including 62 patients undergoing ESS for chronic rhinosinusitis in a single tertiary referral hospital. INTERVENTIONS: Participants were randomized to receive 1 g of IVAPAP or 100 mL of placebo consisting of saline infusions immediately before the start of surgery and 4 hours after the initial dose. MAIN OUTCOMES AND MEASURES: The primary outcome was postoperative pain measured by visual analog scale (VAS) scores up to 24 hours after surgery by blinded observers. Secondary endpoints included postoperative opioid (intravenous and oral) use and adverse events in the 24-hour postoperative period. RESULTS: Of the 62 enrolled adult participants, 60 were randomized (31 to IVAPAP intervention and 29 to placebo). The mean (SD) age of participants was 53.7 (14.7) years and 35 (58%) of the participants were men and 25 (42%) were women. Within the first hour, mean pain scores were reduced in the IVAPAP group compared with the control group, reaching a maximum difference of 7.7 mm on a VAS scale favoring the treatment group with a true difference possibly as high as 22 mm, and the data are compatible with a clinically meaningful difference. At 12- and 24-hours, average pain scores were less in the placebo group and the data are compatible with a clinically meaningful difference of 5.8 (-5.2 to 16.8) and 8.2 (-1.9 to 18.4), respectively, favoring the placebo group. However, at all time points the CIs included the null value and were wide, thus preventing definitive conclusions. Inspection of the secondary outcomes favored IVAPAP, but the wide range of the CIs and inclusion of the null value prevent definitive conclusions. CONCLUSIONS AND RELEVANCE: The results of this study are inconclusive. The data suggest that perioperative intravenous acetaminophen may reduce immediate postoperative pain and opioid requirements compared with placebo and these differences could be clinically meaningful. Unfortunately, the imprecision of the estimates prevents definitive conclusion. Use of IVAPAP does not seem to increase adverse events. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01608308.
引用
- Tyler MA, Lam K, Ashoori F, et al. Analgesic Effects of Intravenous Acetaminophen vs Placebo for Endoscopic Sinus Surgery and Postoperative Pain: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28542675. doi:10.1001/jamaoto.2017.0238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。